Abstract:Summary: The study of a 5-year old patient with a mucopolysaccharidosis different from those already known has given the opportunity to describe the clinical, biochemical and enzymic characteristics of JV-acetylglucosamine-6-sulfate sulfatase deficiency.The patient was delayed physically and mentally, was hyperactive, and had a short attention span. He had fair complexion and very blond, but coarse and excessive hair. He had mild hepato-splenomegaly and dysostosis multiplex, including hypoplastic odontoid process of the atlas, ovoid vertebral bodies, small femoral epiphyses, and modest enlargement of the ribs. He had a mild, bilateral conductive hearing loss. The urine gave a strongly positive spot test with Azur A paper. Quantitative measurement of urinary glycosaminoglycans demonstrated increased excretion and inadequate degradation of heparan sulfate and keratan sulfate. The microscopic examination of the stained peripheral leukocytes revealed metachromatic material which formed a ring on the inner aspect of the cellular membrane in 20% of the lymphocytes. The rate of degradation of 35SO4-labeled intracellular glycosaminoglycans by cutaneous fibroblasts was delayed and inadequate.The measurements of several lysosomal enzymes whose deficiencies are responsible for the known mucopolysaccharidoses gave results within normal ranges. GaIactose-6-sulfate (Gal-6-S), N-acetylgalactosamine-6-sulfate (GalNAc-6-S), and N-acetylglu-cosamine-6-sulfate (GlcNAc-6-S) were prepared with chlorosulfonic acid, according to the method of Suzuki and Strominger (38). After chromatographic purification, aliquots of the three 6-sulfated monosaccharides were reduced with sodium borotritide. Measurements of Gal-6-S sulfatase, GalNAc-6-S sulfatase, and GlcNAc-6-S sulfatase were performed on extracts of normal cultured fibroblasts and of fibroblasts of the propositus, his parents, and several Morquio patients. Additionally, GalNAc-6-S sulfatase and GlcNAc-6-S sulfatase activities were also measured, using as substrate 500 nmol tetrasaccharide obtained from either chon-droitin-6-sulfate or nonradioactive GlcNAc-6-S. The measurement demonstrated that the propositus has a defective GlcNAc-6-S sulfatase activity, but normal activities for Gal-6-S and GalNAc-6-S sulfatase.These findings are in contrast with those found with fibroblast extracts of Morquio patients, since they have low or nondetectable activities of Gal-6-S and GalNAc-6-S sulfatase but normal GlcNAc-6-S sulfatase activity.Extracts of leukocytes and fibroblasts of the propositus' parents, when tested with radioactive or nonradioactive substrates, had normal levels of GalNAc-6-S sulfatase activity but decreased levels of GlcNAc-6-S sulfatase activity (50–60% of normal).Speculation: The possible existence of two different sulfatases, specific for 6-sulfated hexoses with the glucose or galactose configuration, has been suggested (10).The study of a patient with a novel mucopolysaccharidosis, characterized by defective degradation of keratan sulfate and heparan sulfate, has provided the opportunity of describing the clinical and biochemical features of GlcNAc-6-S sulfatase deficiency. These findings confirm that the defective degradation of keratan sulfate and chondroitin-6-sulfate typical of classic Morquio disease is caused by the deficiency of a sulfatase specific for Gal-6-S and GalNAc-6-S.

Mucopolisacharidosis: Case Report.

"Mucopolysaccharidosis syndrome in a 9-Year-old boy: oral-dental management and diagnostic considerations": a case report

Glycosaminoglycans in mucopolysaccharidoses and other disorders

Mucopolysaccharidosis Type I: The Importance of Early Diagnosis for Adequate Treatment

ENT and mucopolysaccharidoses

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology

Typical presentation of mucopolysaccharidosis type IVA: a case report

Analysis of endocrine hormone metabolism level in a Chinese patient with mucopolysaccharidosis IVA: A case report.

Long-term Effects of Enzyme Replacement Therapy for Taiwanese Patients with Mucopolysaccharidosis IVA.

Case Report: Diagnosis of Mucopolysaccharidosis Type IVA with Compound Heterozygous Galactosamine-6 Sulfatase Variants and Biopsy of Replaced Femoral Heads

A Basic Understanding of Mucopolysaccharidosis: Incidence, Clinical Features, Diagnosis, and Management.

N-Acetylglucosamine-6-Sulfate Sulfatase in Man: Deficiency of the Enzyme in a New Mucopolysaccharidosis

A Basic Understanding Of Mucopolysaccharidosis: Incidence, Clinical Features, Diagnosis, And Management

Advances in the Diagnosis and Treatment for Ocular Complication on Mucopolysaccharidosis

Clinical Characteristics and Enzyme Assays of 35 Cases with Mucopolysaccharidosis Type IV

Evaluation of orofacial motricity in patients with mucopolysaccharidosis: a cross-sectional study

Otorhinolaryngological Problems in Mucopolysaccharidoses: A Review of Common Symptoms in a Rare Disease

Clinical and GUSB Gene Analysis of a Patient with Mucopolysaccharidosis Type Ⅶ and Prenatal Diagnosis for Her Sibling

Clinical manifestations and genetic mutation analysis of patients with mucopolysaccharidosis type VII in China

Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy

[Enzymatic Diagnosis of 47 Cases with Mucopolysaccharidosis].